{"id":"W2519988759","doi":"10.2196/resprot.5872","title":"EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia","year":2016,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"International Fund for Agricultural Development; United Nations High Commissioner for Refugees; United Nations Development Programme; National Heart, Lung, and Blood Institute; Pan American Health Organization; International Labour Organization; United Nations Population Fund; International Atomic Energy Agency; UNICEF; United Nations Educational, Scientific and Cultural Organization","keywords":"Medicine; Open label; Disease; Clinical trial; Anemia; Sickle cell anemia; Pediatrics; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001739995,0.001454683,0.001746624,0.0003170079,0.0004392534,0.0008833737,0.0009007299,0.001428381,0.004528335],"category_scores_gemma":[0.001232016,0.0003774452,0.0009778542,0.0002339042,0.001026748,0.001010814,0.00056233,0.00249014,0.0005409977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005236541,"about_ca_system_score_gemma":0.001096885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001043889,"about_ca_topic_score_gemma":0.002601498,"domain_scores_codex":[0.9995145,0.0002510917,0.00002578652,0.00007715005,0.0000429573,0.0000885404],"domain_scores_gemma":[0.9987693,0.0002797929,0.0002854709,0.0001022353,0.00007601707,0.0004871102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9113991,0.04797828,0.003728381,0.0006426019,0.0006969752,0.0002244588,0.000226817,0.0009190431,0.0066086,0.0002642699,0.001685933,0.02562545],"study_design_scores_gemma":[0.7917797,0.1986432,0.006805955,0.00005231646,0.0002246309,0.0001313854,0.00004912104,0.0004761858,0.0006354196,0.0001688204,0.001015002,0.00001828623],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9942833,0.001060417,0.0002582082,0.0002667745,0.00008831461,0.002073031,0.0008635573,0.00005095464,0.001055516],"genre_scores_gemma":[0.9834639,0.001617594,0.002146868,0.001168577,0.0003299289,0.00552668,0.002458637,0.00002028745,0.003267576],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.004528335,"threshold_uncertainty_score":0.01514882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4767839617624962,"score_gpt":0.6143123563726977,"score_spread":0.1375283946102014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}